These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 12685842

  • 1. Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.
    Styczynski J, Wysocki M, Debski R, Juraszewska E, Malinowska I, Stanczak E, Ploszynska A, Stefaniak J, Mazur B, Szczepanski T.
    Leuk Lymphoma; 2002 Sep; 43(9):1843-8. PubMed ID: 12685842
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
    Styczynski J, Wysocki M, Debski R, Czyzewski K, Balwierz W, Juraszewska E, Matysiak M, Malinowska I, Stanczak E, Sońta-Jakimczyk D, Szczepanski T, Wachowiak J, Konatkowska B, Balcerska A, Ploszynska A, Kowalczyk J, Stefaniak J, Badowska W, Wieczorek M, Olejnik I, Krawczuk-Rybak M, Kuzmicz M.
    Neoplasma; 2005 Sep; 52(1):74-8. PubMed ID: 15739031
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Drug-resistance Profile in Multiple-relapsed Childhood Acute Lymphoblastic Leukemia.
    Pogorzala M, Kubicka M, Rafinska B, Wysocki M, Styczynski J.
    Anticancer Res; 2015 Oct; 35(10):5667-70. PubMed ID: 26408741
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Individual tumor response testing in multiple relapsed acute myeloid leukemia in children.
    Styczynski J, Piatkowska M, Czyzewski K, Pogorzala M, Wysocki M.
    Anticancer Res; 2013 Mar; 33(3):1189-93. PubMed ID: 23482801
    [Abstract] [Full Text] [Related]

  • 10. Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.
    Zwaan CM, Kaspers GJ, Pieters R, Hählen K, Huismans DR, Zimmermann M, Harbott J, Slater RM, Creutzig U, Veerman AJ.
    Blood; 2002 Nov 01; 100(9):3352-60. PubMed ID: 12384437
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activity of glufosfamide in childhood acute leukemia.
    Styczynski J, Wysocki M, Kurylak A, Juraszewska E, Malinowska I, Stanczak E, Płoszynska A, Stefaniak J, Mazur B, Szczepanski T, Ras M.
    Anticancer Res; 2002 Nov 01; 22(1A):247-50. PubMed ID: 12017297
    [Abstract] [Full Text] [Related]

  • 13. Relationship between in vitro chemosensitivity assessed with MTT assay and clinical outcomes in 103 patients with acute leukemia.
    Jun KR, Jang S, Chi HS, Lee KH, Lee JH, Choi SJ, Seo JJ, Moon HN, Im HJ, Park CJ.
    Korean J Lab Med; 2007 Apr 01; 27(2):89-95. PubMed ID: 18094557
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.
    Styczyński J, Wysocki M, Balwierz W, Rokicka-Milewska R, Matysiak M, Balcerska A, Kowalczyk A, Wachowiak J, Sońta-Jakimczyk D, Chybicka A.
    Neoplasma; 2002 Apr 01; 49(3):178-83. PubMed ID: 12098004
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S, Paydas S, Disel U, Sahin B.
    Am J Ther; 2006 Apr 01; 13(5):389-93. PubMed ID: 16988532
    [Abstract] [Full Text] [Related]

  • 18. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N, Sarper N, Devecioğlu O, Anak S, Eryilmaz E, Can M, Yenilmez H, Ağaoğlu L, Gedikoğlu G.
    Turk J Pediatr; 2000 Apr 01; 42(3):198-204. PubMed ID: 11105617
    [Abstract] [Full Text] [Related]

  • 19. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
    Zwaan CM, Kaspers GJ, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wünsche R, Rottier MM, Hählen K, van Wering ER, Janka-Schaub GE, Creutzig U, Veerman AJ.
    Blood; 2000 Oct 15; 96(8):2879-86. PubMed ID: 11023525
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.
    Savaşan S, Buck S, Ozdemir O, Hamre M, Asselin B, Pullen J, Ravindranath Y.
    Leuk Lymphoma; 2005 Jun 15; 46(6):833-40. PubMed ID: 16019527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.